Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.3200
-0.0050 (-1.54%)
At close: Sep 28, 2026
Anebulo Pharmaceuticals Employees
As of June 30, 2025, Anebulo Pharmaceuticals had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
13.05M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 3 | 0 | - | 2 | 1 |
| Jun 30, 2024 | 3 | 1 | 50.00% | 2 | 1 |
| Jun 30, 2023 | 2 | -2 | -50.00% | 2 | 0 |
| Jun 30, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Jun 30, 2021 | 3 | - | - | 2 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncotelic Therapeutics | 43 |
| Zeo ScientifiX | 20 |
| Brainstorm Cell Therapeutics | 19 |
| Inhibitor Therapeutics | 8 |
| ZIVO Bioscience | 7 |
| Hepion Pharmaceuticals | 2 |
| Synlogic | 1 |
Anebulo Pharmaceuticals News
- 7 months ago - Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates - Business Wire
- 7 months ago - Anebulo Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 7 months ago - Anebulo Pharmaceuticals Earnings release: Q2 2026 - Filings
- 7 months ago - Anebulo Pharmaceuticals to voluntarily delist from Nasdaq - TheFly
- 7 months ago - Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC - Business Wire
- 8 months ago - Anebulo Pharmaceuticals Announces Final Results of Tender Offer - Business Wire
- 8 months ago - Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer - Business Wire
- 9 months ago - Anebulo announces cash tender offer of 300,000 shares at $3.50 per share - TheFly